Prognostic factors in surgically treated tongue squamous cell carcinoma in stage T1‐2N0‐1M0: A retrospective analysis
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | Wenxi Wang, Yuxiang Wang, Wenhui Zeng, Xubin Xie, Chen Li, Qin Zhou, Liangfang Shen |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Obesity enhances the response to neoadjuvant anti‐ PD1 therapy in oral tongue squamous cell carcinoma
di: Xiyan Tan, et al.
Pubblicazione: (2024)
di: Xiyan Tan, et al.
Pubblicazione: (2024)
Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma
di: Jie Hu, et al.
Pubblicazione: (2024)
di: Jie Hu, et al.
Pubblicazione: (2024)
Comparison of the TNM9th and 8th editions for localized and locally advanced anal squamous cell carcinoma treated nonsurgically and proposal of a new stage grouping system
di: Aihong Zheng, et al.
Pubblicazione: (2024)
di: Aihong Zheng, et al.
Pubblicazione: (2024)
Prognostic value of preoperative combined neutrophil, monocyte, and lymphocyte scores in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A retrospective study
di: Jinliang Ni, et al.
Pubblicazione: (2024)
di: Jinliang Ni, et al.
Pubblicazione: (2024)
Clinical factor‐based risk stratification for precision therapy in locally advanced squamous cell carcinoma of the uterine cervix
di: Feng‐Yuan Liu, et al.
Pubblicazione: (2024)
di: Feng‐Yuan Liu, et al.
Pubblicazione: (2024)
Exploring the factors affecting the occurrence of postoperative MVI and the prognosis of hepatocellular carcinoma patients treated with hepatectomy: A multicenter retrospective study
di: Jilin Yang, et al.
Pubblicazione: (2024)
di: Jilin Yang, et al.
Pubblicazione: (2024)
Notch signaling genes and CD8+ T‐cell dynamics: Their contribution to immune‐checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study
di: Kazuhiro Ogi, et al.
Pubblicazione: (2024)
di: Kazuhiro Ogi, et al.
Pubblicazione: (2024)
Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis
di: Masayo Hasegawa, et al.
Pubblicazione: (2024)
di: Masayo Hasegawa, et al.
Pubblicazione: (2024)
Roles of intralesional bacteria in the initiation and progression of oral squamous cell carcinoma
di: Zhuoyan Luo, et al.
Pubblicazione: (2024)
di: Zhuoyan Luo, et al.
Pubblicazione: (2024)
Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma
di: Qing Liu, et al.
Pubblicazione: (2024)
di: Qing Liu, et al.
Pubblicazione: (2024)
Prediction of prognosis in oral squamous cell carcinoma using infrared microspectroscopy
di: Conor A. Whitley, et al.
Pubblicazione: (2024)
di: Conor A. Whitley, et al.
Pubblicazione: (2024)
Clinicopathological and genomic features of superficial esophageal squamous cell carcinomas in nondrinker, nonsmoker females
di: Motomitsu Fukuhara, et al.
Pubblicazione: (2024)
di: Motomitsu Fukuhara, et al.
Pubblicazione: (2024)
Nc‐RNA‐mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma
di: Xinyi Zeng, et al.
Pubblicazione: (2024)
di: Xinyi Zeng, et al.
Pubblicazione: (2024)
Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
di: Guihong Liu, et al.
Pubblicazione: (2024)
di: Guihong Liu, et al.
Pubblicazione: (2024)
Expression of PTGS2 along with genes regulating VEGF signalling pathway and association with high‐risk factors in locally advanced oral squamous cell carcinoma
di: Mehta Vedant Kamal, et al.
Pubblicazione: (2024)
di: Mehta Vedant Kamal, et al.
Pubblicazione: (2024)
The outcomes of different regimens depend on the molecular subtypes of pulmonary large‐cell neuroendocrine carcinoma: A retrospective study in China
di: Zhaojue Wang, et al.
Pubblicazione: (2024)
di: Zhaojue Wang, et al.
Pubblicazione: (2024)
Artificial intelligence for oral squamous cell carcinoma detection based on oral photographs: A comprehensive literature review
di: Jérôme de Chauveron, et al.
Pubblicazione: (2024)
di: Jérôme de Chauveron, et al.
Pubblicazione: (2024)
Early recurrence, time‐to‐recurrence, and recurrence patterns: Assessing their impact on survival outcomes in head and neck squamous cell carcinoma (R/M‐HNSCC) patients treated with first line platinum‐based chemotherapy
di: Pasvich Pitakpaiboonkul, et al.
Pubblicazione: (2024)
di: Pasvich Pitakpaiboonkul, et al.
Pubblicazione: (2024)
Caucasian validation of downstaging from IIB to IIA in T1N1M0 patients within the 9th edition of the non‐small cell lung cancer tumor‐node‐metastasis staging
di: Jingsheng Cai, et al.
Pubblicazione: (2024)
di: Jingsheng Cai, et al.
Pubblicazione: (2024)
High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma
di: Ayaka Tajiri, et al.
Pubblicazione: (2024)
di: Ayaka Tajiri, et al.
Pubblicazione: (2024)
Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system?
di: Tsung‐Ming Chen, et al.
Pubblicazione: (2024)
di: Tsung‐Ming Chen, et al.
Pubblicazione: (2024)
Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
di: Xiaofeng Duan, et al.
Pubblicazione: (2024)
di: Xiaofeng Duan, et al.
Pubblicazione: (2024)
Toxicity profiles of immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta‐analysis
di: Shoutao Dang, et al.
Pubblicazione: (2024)
di: Shoutao Dang, et al.
Pubblicazione: (2024)
Predictive capacity of immune‐related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma
di: Angela E. Alnemri, et al.
Pubblicazione: (2024)
di: Angela E. Alnemri, et al.
Pubblicazione: (2024)
Application of interpretable machine learning algorithms to predict distant metastasis in ovarian clear cell carcinoma
di: Qin‐Hua Guo, et al.
Pubblicazione: (2024)
di: Qin‐Hua Guo, et al.
Pubblicazione: (2024)
Contrasting clinical outcomes and socio‐economic impact of young versus elderly‐onset oral squamous cell carcinoma, a novel health economic analysis
di: Manraj Singh, et al.
Pubblicazione: (2024)
di: Manraj Singh, et al.
Pubblicazione: (2024)
Prognostic significance of systemic immune‐inflammation index in patients with nonfunction pancreatic neuroendocrine tumor undergoing surgical resection
di: Guanhua Chen, et al.
Pubblicazione: (2024)
di: Guanhua Chen, et al.
Pubblicazione: (2024)
Risk factors for lenvatinib‐induced palmar‐plantar erythrodysesthesia syndrome in patients with hepatocellular carcinoma: A retrospective study
di: Shusuke Uekusa, et al.
Pubblicazione: (2024)
di: Shusuke Uekusa, et al.
Pubblicazione: (2024)
Health‐related quality of life in patients with metastatic basal cell carcinoma treated with cemiplimab: Analysis of a phase 2 trial
di: Ketty Peris, et al.
Pubblicazione: (2024)
di: Ketty Peris, et al.
Pubblicazione: (2024)
The augmentation of cytotoxic immune cell functionality through physical exertion bolsters the potency of chemotherapy in models of mammary carcinoma
di: Bingqing Qin, et al.
Pubblicazione: (2024)
di: Bingqing Qin, et al.
Pubblicazione: (2024)
Bilateral Neck Dissection Effectively Improves Prognosis of Patients With T3N0M0 Glottic Carcinoma
di: Bixue Huang, et al.
Pubblicazione: (2026)
di: Bixue Huang, et al.
Pubblicazione: (2026)
Brain metastases in patients with salivary duct carcinoma: A retrospective study
di: Chihiro Fushimi, et al.
Pubblicazione: (2024)
di: Chihiro Fushimi, et al.
Pubblicazione: (2024)
Prognostic Factors in Patients With Locally Advanced Hypopharyngeal Squamous Cell Carcinoma After Radical Radiotherapy/Chemoradiotherapy
di: Xinyue Qu, et al.
Pubblicazione: (2025)
di: Xinyue Qu, et al.
Pubblicazione: (2025)
A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study
di: Fatih Gürler, et al.
Pubblicazione: (2024)
di: Fatih Gürler, et al.
Pubblicazione: (2024)
Knockdown of p53 Enhances LncRNA A2M‐AS1 Inhibition of Pancreatic Cancer Progression via Regulating MAPK Pathway
di: Yu Cen, et al.
Pubblicazione: (2025)
di: Yu Cen, et al.
Pubblicazione: (2025)
Real‐world study on the characteristics, post‐nephrectomy journey, and outcomes of patients with early‐stage renal cell carcinoma based on risk groups
di: Jose A. Karam, et al.
Pubblicazione: (2024)
di: Jose A. Karam, et al.
Pubblicazione: (2024)
Impact of immune‐related adverse events on survival outcomes in extensive‐stage small cell lung cancer patients treated with immune checkpoint inhibitors
di: Tadashi Nishimura, et al.
Pubblicazione: (2024)
di: Tadashi Nishimura, et al.
Pubblicazione: (2024)
Analysis of related factors of CRA in lung cancer patients with different serum iron levels: A retrospective cohort study
di: Quan‐yao Li, et al.
Pubblicazione: (2024)
di: Quan‐yao Li, et al.
Pubblicazione: (2024)
Quality of life and patient‐reported toxicities in patients with advanced Merkel cell carcinoma treated with combined nivolumab and ipilimumab with or without stereotactic body radiation therapy
di: Aasha I. Hoogland, et al.
Pubblicazione: (2024)
di: Aasha I. Hoogland, et al.
Pubblicazione: (2024)
Immunotherapy combined with antiangiogenic therapy as third‐ or further‐line therapy for stage IV non‐small cell lung cancer patients with ECOG performance status 2: A retrospective study
di: Shuo Li, et al.
Pubblicazione: (2024)
di: Shuo Li, et al.
Pubblicazione: (2024)
Documenti analoghi
-
Obesity enhances the response to neoadjuvant anti‐ PD1 therapy in oral tongue squamous cell carcinoma
di: Xiyan Tan, et al.
Pubblicazione: (2024) -
Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma
di: Jie Hu, et al.
Pubblicazione: (2024) -
Comparison of the TNM9th and 8th editions for localized and locally advanced anal squamous cell carcinoma treated nonsurgically and proposal of a new stage grouping system
di: Aihong Zheng, et al.
Pubblicazione: (2024) -
Prognostic value of preoperative combined neutrophil, monocyte, and lymphocyte scores in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A retrospective study
di: Jinliang Ni, et al.
Pubblicazione: (2024) -
Clinical factor‐based risk stratification for precision therapy in locally advanced squamous cell carcinoma of the uterine cervix
di: Feng‐Yuan Liu, et al.
Pubblicazione: (2024)